| Ytd | 29.08% | |
| 1y | 51.80% |
| Open | 44.42 | Prev Close | 43.95 | Low | 44.12 | High | 44.96 | Mkt Cap | 2.75B |
| Vol | 266.09K | Avg Vol | 790.92K | EPS | -0.84 | P/E | -52.32 | Forward P/E | 1000.00 |
| Beta | 1.27 | Short Ratio | 4.68 | Inst. Own | 103.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 44.48 | 200-d Avg | 39.58 | 1yr Est | 56.25 |
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-08-10 | 2026-06 | 0.29 | N/A | N/A | N/A |
| 2026-05-11 | 2026-03 | -0.1 | -0.11 | -0.01 | -10.00% |
| 2026-02-25 | 2025-12 | 0.07 | 0.12 | 0.05 | 71.43% |
| 2025-11-05 | 2025-09 | 0.26 | -0.17 | -0.43 | -165.38% |
| 2025-08-06 | 2025-06 | 0.68 | -0.68 | -1.36 | -200.00% |
| 2025-05-12 | 2025-03 | 0.4 | -0.23 | -0.63 | -157.34% |
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-06-29 | BWS Financial | Upgrade | Buy | Buy |
| 2026-05-07 | Barclays | Upgrade | Equal-Weight | Overweight |
| 2026-04-17 | BTIG | Upgrade | Buy | Buy |
| 2026-04-15 | Citigroup | Upgrade | Neutral | Neutral |
| 2026-04-07 | BWS Financial | Upgrade | Buy | Buy |
| 2026-03-05 | Citigroup | Upgrade | Sell | Neutral |
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2026-04-23 | ALI SAMIR H | Chief Executive Officer | 44.76K | Conversion of Exercise of derivative security |
| 2026-05-13 | CAHUZAC JEAN P | Director | 7.27K | Conversion of Exercise of derivative security |
| 2026-06-10 | CREED GRANT RUSSEL | Chief Financial Officer | 23.06K | Sale |
| 2025-12-30 | JOHNSON SIMON WILLIAM | Chief Executive Officer | 137.19K | Conversion of Exercise of derivative security |
| 2026-05-13 | MCCOLLUM MARK A | Director | 7.27K | Conversion of Exercise of derivative security |
| 2026-05-13 | QUARLS HARRY | Director | 16.27K | Conversion of Exercise of derivative security |
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | BlackRock Inc | 4.95M | 0.00 | 7.91% |
| 2026-03-30 | Elliott Investment Management LP | 4.72M | 0.00 | 7.55% |
| 2025-12-30 | Vanguard Group Inc | 3.81M | 0.00 | 6.09% |
| 2026-03-30 | UBS Group AG | 3.81M | 0.00 | 6.09% |
| 2026-03-30 | Dimensional Fund Advisors, Inc. | 3.55M | 0.00 | 5.68% |
| 2026-03-30 | Vanguard Capital Management, LLC | 2.69M | 0.00 | 4.30% |
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-04-29 | Vanguard Total Stock Mkt Idx Inv | 1.89M | 0.00 | 3.02% |
| 2026-03-30 | Patient Opportunity C | 1.53M | 0.00 | 2.44% |
| 2026-05-28 | iShares Russell 2000 ETF | 1.50M | 0.00 | 2.40% |
| 2026-05-29 | Avantis US Small Cap Value ETF | 1.14M | 0.00 | 1.83% |
| 2026-04-29 | Goehring & Rozencwajg Resources Instl | 1.09M | 0.00 | 1.74% |
| 2026-04-29 | DFA US Small Cap Value I | 805.05K | 0.00 | 1.29% |
| Dividend | Date |
|---|---|
| 0.0037 | 2014-09-04 |
| 0.0037 | 2014-06-10 |
| 0.0037 | 2014-03-05 |
| 0.0035 | 2013-12-03 |
| 0.0034 | 2013-09-05 |
| 0.0033 | 2013-06-05 |
| Split | Date |
|---|---|
| 100 : 26777 | 2018-07-03 |